← Open Payments lookup

LUIS BENALCAZAR: Open Payments

NPI 1801878269 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$702 in 40 payments from 15 companies in 2025. Trend: 2023 $1,905 · 2024 $868 · 2025 $702

Food & beverage: $702
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$206
Boehringer Ingelheim Pharmaceuticals, Inc.7$139
Abbott Laboratories4$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$54
Aimmune Therapeutics, Inc.2$36
Amgen Inc.2$31
Novo Nordisk Inc2$29
Dexcom, Inc.1$28
Lilly USA, LLC1$22
Otsuka America Pharmaceutical, Inc.1$21

Products named: JARDIANCE, FARXIGA, FREESTYLE LIBRE 3, XIFAXAN, BREZTRI, ZENPEP, OTEZLA, Dexcom G6 Transmitter.

Industry payments across NJ — which companies pay providers there.